Offenbartl K, Gullstrand P, Alwmark A, Christensen P
Acta Pathol Microbiol Immunol Scand B. 1984 Aug;92(4):213-6. doi: 10.1111/j.1699-0463.1984.tb02823.x.
Normal and splenectomized rats were challenged with Streptococcus pneumoniae type 1 via different administration routes. In experiment I, previously splenectomized or sham-operated rats received 4 X 10(3) colony-forming units (CFU) of pneumococci via (i) a peripheral vein, (ii) subcutaneously, or (iii) intraperitoneally. The results indicated an increased susceptibility of the splenectomized animal to pneumococci administered via all three routes. However, subcutaneously administered pneumococci gave a lower mortality than pneumococci given intravenously or intraperitoneally. In experiment II 40 splenectomized rats received 4 X 10(3) CFU of pneumococci via (i) peripheral, (ii) portal, or (iii) caval veins or the aorta. No differences in mortality were found. In experiment III, non-operated animals received 4 X 10(5) CFU of pneumococci either intravenously or intraperitoneally, resulting in mortality rates of 0/20 and 17/20, respectively. After 2 weeks the rats surviving intravenous challenge received 4 X 10(5) CFU of pneumococci intraperitoneally; all survived. The data indicate the the spleen and the subcutis have a greater capacity to protect against pneumococci in the absence of specific antibody than the peritoneum or the circulation outside the spleen.
正常大鼠和脾切除大鼠通过不同给药途径用1型肺炎链球菌进行攻击。在实验I中,先前已进行脾切除或假手术的大鼠通过以下方式接受4×10³集落形成单位(CFU)的肺炎球菌:(i)外周静脉,(ii)皮下,或(iii)腹腔内。结果表明,脾切除动物对通过所有三种途径给药的肺炎球菌的易感性增加。然而,皮下给药的肺炎球菌的死亡率低于静脉内或腹腔内给药的肺炎球菌。在实验II中,40只脾切除大鼠通过(i)外周静脉、(ii)门静脉、(iii)腔静脉或主动脉接受4×10³CFU的肺炎球菌。未发现死亡率有差异。在实验III中,未手术的动物静脉内或腹腔内接受4×10⁵CFU的肺炎球菌,死亡率分别为0/20和17/20。静脉攻击后存活2周的大鼠腹腔内接受4×10⁵CFU的肺炎球菌;全部存活。数据表明,在没有特异性抗体的情况下,脾脏和皮下组织比腹膜或脾脏外循环具有更强的抵御肺炎球菌的能力。